1. Home
  2. GBTG vs TNGX Comparison

GBTG vs TNGX Comparison

Compare GBTG & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Business Travel Group Inc.

GBTG

Global Business Travel Group Inc.

HOLD

Current Price

$5.70

Market Cap

2.9B

Sector

Technology

ML Signal

HOLD

Logo Tango Therapeutics Inc.

TNGX

Tango Therapeutics Inc.

HOLD

Current Price

$25.66

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GBTG
TNGX
Founded
2014
2014
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
GBTG
TNGX
Price
$5.70
$25.66
Analyst Decision
Buy
Strong Buy
Analyst Count
6
10
Target Price
$8.92
$20.00
AVG Volume (30 Days)
1.2M
2.7M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
173.33
26.89
EPS
0.22
N/A
Revenue
$2,718,000,000.00
$62,384,000.00
Revenue This Year
$21.78
N/A
Revenue Next Year
$4.32
N/A
P/E Ratio
$26.86
N/A
Revenue Growth
12.17
48.29
52 Week Low
$4.96
$1.04
52 Week High
$8.64
$28.41

Technical Indicators

Market Signals
Indicator
GBTG
TNGX
Relative Strength Index (RSI) 48.16 64.91
Support Level $5.20 $6.54
Resistance Level $5.88 N/A
Average True Range (ATR) 0.25 1.62
MACD 0.03 0.27
Stochastic Oscillator 40.49 69.08

Price Performance

Historical Comparison
GBTG
TNGX

About GBTG Global Business Travel Group Inc.

Global Business Travel Group Inc operates as a business-to-business travel platform. It is engaged in providing software and services to manage travel, expenses, and meetings and events for companies of all sizes. The company is engaged in building the marketplace in B2B travel to deliver unrivaled choice, value, and experiences. It also provides business travel solutions, simplified travel management, and business consulting services. Further, The company generates revenue in two ways that involves fees and other revenues relating to processing and servicing travel transactions received from clients and travel suppliers and revenues for the provision of products and professional services not directly related to transactions received from clients, travel suppliers and Network Partners.

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

Share on Social Networks: